Inflammatory effects of inhaled sulfur mustard in rat lung

Toxicology and Applied Pharmacology

Volumn 248, Issue 2, 2010, Pages 89-99

  Malaviya, Rama ^a   Sunil, Vasanthi R ^a   Cervelli, Jessica ^a   Anderson, Dana R ^b   Holmes, Wesley W ^b   Conti, Michele L ^b   Gordon, Ronald E ^c   Laskin, Jeffrey D ^d   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Autophagy; Inflammation; Lung; Sulfur mustard; Vesicant

Indexed keywords

BIOLOGICAL MARKER; COLLECTIN; CYCLOOXYGENASE 2; GELATINASE B; HEME OXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MUSTARD GAS; PROTEIN; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CHEMICAL WARFARE AGENT;

ANESTHESIA; ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BRONCHUS INJURY; BRONCHUS MUCOSA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; ENDOTRACHEAL INTUBATION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG ALVEOLUS WALL; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RESPIRATORY TRACT MUCOSA; TRACHEA INJURY; ULCER; VAPOR; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; LUNG; METABOLISM; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; AUTOPHAGY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMICAL WARFARE AGENTS; LUNG; MALE; MUSTARD GAS; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 77956921526     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.07.018     Document Type: Article

References (67)

1. Allon N., Amir A., Manisterski E., Rabinovitz I., Dachir S., Kadar T. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicol. Appl. Pharmacol. 2009, 241:154-162.
2. Anderson D.R., Yourick J.J., Moeller R.B., Petrali J.P., Young G.D., Byers S.L. Pathological changes in rat lungs following acute sulfur mustard inhalation. Inhal. Toxicol. 1996, 8:285-297.
3. Anderson D.R., Byers S.L., Vesely K.R. Treatment of sulfur mustard (HD)-induced lung injury. J. Appl. Toxicol. 2000, 20:S129-S132.
4. Anderson D.R., Holmes W.W., Lee R.B., Dalal S.J., Hurst C.G., Maliner B.I., Newmark J., Smith W.J. Sulfur mustard-induced neutropenia: treatment with granulocyte colony-stimulating factor. Mil. Med. 2006, 171:448-453.
5. Anderson D.R., Taylor S.L., Fetterer D.P., Holmes W.W. Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury. Toxicology 2009, 263:41-46.
6. Atochina-Vasserman E.N., Beers M.F., Kadire H., Tomer Y., Inch A., Scott P., Guo C.J., Gow A.J. Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in surfactant protein D-deficient mice. J. Immunol. 2007, 179:8090-8097.
7. Babin M.C., Ricketts K., Skvorak J.P., Gazaway M., Mitcheltree L.W., Casillas R.P. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol. 2000, 20:S141-S144.
8. Balali-Mood M., Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin. Pharmacol. Toxicol. 2006, 99:273-282.
9. Beheshti J., Mark E.J., Akbaei H.M., Aslani J., Ghanei M. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol. Res. Pract. 2006, 202:739-744.
10. Bhalla D.K. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, mechanisms, and implications. J. Toxicol. Environ. Health B Crit. Rev. 1999, 2:31-86.
11. Calvet J.H., D'Ortho M.P., Jarreau P.H., Levame M., Harf A., Macquin-Mavier I. Glucocorticoids inhibit sulfur mustard-induced airway muscle hyperresponsiveness to substance P. J. Appl. Physiol. 1994, 77:2325-2332.
12. Calvet J.H., Jarreau P.H., Levame M., D'Ortho M.P., Lorino H., Harf A., Macquin-Mavier I. Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J. Appl. Physiol. 1994, 76:681-688.
13. Calvet J.H., Coste A., Levame M., Harf A., Macquin-Mavier I., Escudier E. Airway epithelial damage induced by sulfur mustard in guinea pigs, effects of glucocorticoids. Hum. Exp. Toxicol. 1996, 15:964-971.
14. Calvet J.H., Planus E., Rouet P., Pezet S., Levame M., Lafuma C., Harf A., D'Ortho M.P. Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am. J. Physiol. 1999, 276:L754-L762.
15. Casillas R.P., Kiser R.C., Truxall J.A., Singer A.W., Shumaker S.M., Niemuth N.A., Ricketts K.M., Mitcheltree L.W., Castrejon L.R., Blank J.A. Therapeutic approaches to dermatotoxicity by sulfur mustard: I. Modulation of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 2000, 20:S145-S151.
16. Chatterjee D., Mukherjee S., Smith M.G., Das S.K. Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J. Biochem. Mol. Toxicol. 2003, 17:114-121.
17. Chen Z.H., Kim H.P., Sciurba F.C., Lee S.J., Feghali-Bostwick C., Stolz D.B., Dhir R., Landreneau R.J., Schuchert M.J., Yousem S.A., Nakahira K., Pilewski J.M., Lee J.S., Zhang Y., Ryter S.W., Choi A.M. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 2008, 3:e3316.
18. Chroneos Z.C., Sever-Chroneos Z., Shepherd V.L. Pulmonary surfactant: an immunological perspective. Cell. Physiol. Biochem. 2010, 25:13-26.
19. Corbel M., Belleguic C., Boichot E., Lagente V. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol. Toxicol. 2002, 18:51-61.
20. Crouch E.C. Surfactant protein-D and pulmonary host defense. Respir. Res. 2000, 1:93-108.
21. Cusimano E.M., Knight A.R., Slusser J.G., Clancy R.L., Pierce J.D. Mitochondria: the hemi of the cell. Adv. Emerg. Nurs. J. 2009, 31:54-62.
22. Debiak M., Kehe K., Burkle A. Role of poly(ADP-ribose) polymerase in sulfur mustard toxicity. Toxicology 2009, 263:20-25.
23. Dillman J.F., McGary K.L., Schlager J.J. Sulfur mustard induces the formation of keratin aggregates in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 2003, 193:228-236.
24. Eisenmenger W., Drasch G., von Clarmann M., Kretschmer E., Roider G. Clinical and morphological findings on mustard gas [bis(2-chloroethyl)sulfide] poisoning. J. Forensic Sci. 1991, 36:1688-1696.
25. Fairhall S.J., Brown R.F., Jugg B.J., Smith A.J., Mann T.M., Jenner J., Sciuto A.M. Preliminary studies of sulphur mustard-induced lung injury in the terminally anesthetized pig: exposure system and methodology. Toxicol. Mech. Methods 2008, 18:355-362.
26. Gao X., Ray R., Xiao Y., Ray P. Suppression of inducible nitric oxide synthase expression and nitric oxide production by macrolide antibiotics in sulfur mustard-exposed airway epithelial cells. Basic Clin. Pharmacol. Toxicol. 2008, 103:255-261.
27. Gao X., Ray R., Xiao Y., Ishida K., Ray P. Macrolide antibiotics improve chemotactic and phagocytic capacity as well as reduce inflammation in sulfur mustard-exposed monocytes. Pulm. Pharmacol. Ther. 2010, 23:97-106.
28. Ghanei M., Harandi A.A. Long term consequences from exposure to sulfur mustard: a review. Inhal. Toxicol. 2007, 19:451-456.
29. Ghanei M., Adibi I., Farhat F., Aslani J. Late respiratory effects of sulfur mustard: how is the early symptoms severity involved?. Chron. Respir. Dis. 2008, 5:95-100.
30. Goven D., Boutten A., Lecon-Malas V., Boczkowski J., Bonay M. Prolonged cigarette smoke exposure decreases heme oxygenase-1 and alters Nrf2 and Bach1 expression in human macrophages: roles of the MAP kinases ERK(1/2) and JNK. FEBS Lett. 2009, 583:3508-3518.
31. Guignabert C., Taysse L., Calvet J.H., Planus E., Delamanche S., Galiacy S., d'Ortho M.P. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L67-L74.
32. Guo C.J., Atochina-Vasserman E.N., Abramova E., Foley J.P., Zaman A., Crouch E., Beers M.F., Savani R.C., Gow A.J. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol. 2008, 6:e266.
33. Hess J.F., FitzGerald P.G. Treatment of keratin intermediate filaments with sulfur mustard analogs. Biochem. Biophys. Res. Commun. 2007, 359:616-621.
34. Kehe K., Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005, 214:198-209.
35. Kehe K., Balszuweit F., Steinritz D., Thiermann H. Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 2009, 263:12-19.
36. Korkmaz A., Yaren H., Topal T., Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch. Toxicol. 2006, 80:662-670.
37. Kumar S. Caspase function in programmed cell death. Cell Death Differ. 2007, 14:32-43.
38. Kumar O., Sugendran K., Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem. Biol. Interact. 2001, 134:1-12.
39. Laskin D.L., Gardner C.R., Laskin J.D. Phagocytes. Immune System Toxicology 2010, vol. 5:133-153. Elsevier, UK. 2nd edition. D. Lawrence (Ed.).
40. Laskin J.D., Heck D.E., Laskin D.L. Nitric oxide pathways in toxic responses. General and Applied Toxicology 2010, Wiley-Blackwell, UK, Chapter 17. B. Ballantyne, T. Marrs, T. Syversen (Eds.).
41. McClintock S.D., Hoesel L.M., Das S.K., Till G.O., Neff T., Kunkel R.G., Smith M.G., Ward P.A. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J. Appl. Toxicol. 2006, 26:126-131.
42. Mol M.A., van den Berg R.M., Benschop H.P. Proteomic assessment of sulfur mustard-induced protein adducts and other protein modifications in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 2008, 230:97-108.
43. Mukherjee S., Stone W.L., Yang H., Smith M.G., Das S.K. Protection of half sulfur mustard gas-induced lung injury in guinea pigs by antioxidant liposomes. J. Biochem. Mol. Toxicol. 2009, 23:143-153.
44. Mukhopadhyay S., Hoidal J.R., Mukherjee T.K. Role of TNFalpha in pulmonary pathophysiology. Respir. Res. 2006, 7:125.
45. Mukhopadhyay S., Mukherjee S., Smith M., Das S.K. Activation of MAPK/AP-1 signaling pathway in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard gas analog. Toxicol. Lett. 2008, 181:112-117.
46. Nyska A., Lomnitski L., Maronpot R., Moomaw C., Brodsky B., Sintov A., Wormser U. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch. Toxicol. 2001, 74:768-774.
47. Oberley-Deegan R.E., Regan E.A., Kinnula V.L., Crapo J.D. Extracellular superoxide dismutase and risk of COPD. COPD 2009, 6:307-312.
48. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr. Protein Pept. Sci. 2002, 3:409-421.
49. O'Neill H.C., White C.W., Veress L.A., Hendry-Hofer T.B., Loader J.E., Min E., Huang J., Rancourt R.C., Day B.J. Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide. Free Radic. Biol. Med. 2010, 48:1188-1196.
50. Papirmeister B., Feister A.J., Robinson S.I., Ford R.D. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications 1991, CRC Press, Boca Raton.
51. Ray R., Keyser B., Benton B., Daher A., Simbulan-Rosenthal C.M., Rosenthal D.S. Sulfur mustard induces apoptosis in cultured normal human airway epithelial cells: evidence of a dominant caspase-8-mediated pathway and differential cellular responses. Drug Chem. Toxicol. 2008, 31:137-148.
52. Ray R., Simbulan-Rosenthal C.M., Keyser B.M., Benton B., Anderson D., Holmes W., Trabosh V.A., Daher A., Rosenthal D.S. Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. Toxicology 2010, 271:94-99.
53. Reddy S.P. The antioxidant response element and oxidative stress modifiers in airway diseases. Curr. Mol. Med. 2008, 8:376-383.
54. Rowell M., Kehe K., Balszuweit F., Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology 2009, 263:9-11.
55. Shakarjian M.P., Heck D.E., Gray J.P., Sinko P.J., Gordon M.K., Casillas R.P., Heindel N.D., Gerecke D.R., Laskin D.L., Laskin J.D. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol. Sci. 2010, 114:5-19.
56. Sinha Roy S., Mukherjee S., Kabir S., Rajaratnam V., Smith M., Das S.K. Inhibition of cholinephosphotransferase activity in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J. Biochem. Mol. Toxicol. 2005, 19:289-297.
57. Soldani C., Scovassi A.I. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 2002, 7:321-328.
58. Sourdeval M., Lemaire C., Deniaud A., Taysse L., Daulon S., Breton P., Brenner C., Boisvieux-Ulrich E., Marano F. Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 2006, 11:1545-1559.
59. Sunil V.R., Patel K.J., Malaviya R., Laskin J.D., Laskin D.L. Inflammatory mediator expression in the lung following exposure to the sulfur mustard analog, 2-chloroethyl sulfide; Role of TNFR1. Am. J. Res. Crit. Care Med 2009, 179:A5863.
60. Torchinsky M.B., Garaude J., Blander J.M. Infection and apoptosis as a combined inflammatory trigger. Curr. Opin. Immunol. 2010, 22:55-62.
61. Uchiyama Y., Shibata M., Koike M., Yoshimura K., Sasaki M. Autophagy-physiology and pathophysiology. Histochem. Cell Biol. 2008, 129:407-420.
62. van Helden H.P., Kuijpers W.C., Diemel R.V. Asthma like symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 2004, 16:537-548.
63. Virgin H.W., Levine B. Autophagy genes in immunity. Nat. Immunol. 2009, 10:461-470.
64. Wigenstam E., Rocksen D., Ekstrand-Hammarstrom B., Bucht A. Treatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injury. Inhal. Toxicol. 2009, 21:958-964.
65. Willems J.L. Clinical management of mustard gas casualties. Ann. Med. Milit. (Belgium) 1989, 3:1-61.
66. Wormser U., Langenbach R., Peddada S., Sintov A., Brodsky B., Nyska A. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. Toxicol. Appl. Pharmacol. 2004, 200:40-47.
67. Yourick J.J., Dawson J.S., Mitcheltree L.W. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J. Appl. Toxicol. 1995, 15:133-138.